We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

95 hedge funds and large institutions have $161M invested in Surgalign Holdings, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 23

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

9% more capital invested

Capital invested by funds: $148M → $161M (+$13.3M)

12% less funds holding

Funds holding: 10895 (-13)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
95
Holders Change
-13
Holders Change %
-12.04%
% of All Funds
2.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
43
Reduced
23
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TA
51
Teton Advisors
New York
$264K
AllianceBernstein
52
AllianceBernstein
Tennessee
$236K
CCMH
53
Cornerstone Capital Management Holdings
New York
$230K -$162K -1,555 -45%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$209K
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$194K +$15.5K +149 +10%
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$188K +$163K +1,566 New
Ameriprise
57
Ameriprise
Minnesota
$180K +$35.5K +341 +30%
TC
58
TFS Capital
Pennsylvania
$169K +$43.6K +419 +43%
Bank of America
59
Bank of America
North Carolina
$159K +$8.22K +79 +6%
JP Morgan Chase
60
JP Morgan Chase
New York
$157K -$128K -1,228 -48%
SRC
61
Shufro Rose & Co
New York
$154K
Federated Hermes
62
Federated Hermes
Pennsylvania
$149K +$520 +5 +0.4%
VOYA Investment Management
63
VOYA Investment Management
Georgia
$144K
AIG
64
American International Group
New York
$141K +$8.12K +78 +7%
NCCM
65
Nine Chapters Capital Management
New Jersey
$140K +$52.5K +504 +76%
Millennium Management
66
Millennium Management
New York
$124K -$47.5K -456 -31%
PPA
67
Parametric Portfolio Associates
Washington
$117K -$282K -2,711 -74%
ARTA
68
A.R.T. Advisors
New York
$109K +$95.2K +915 New
CAM
69
ClariVest Asset Management
California
$98K +$4.27K +41 +5%
PPCM
70
Pillar Pacific Capital Management
California
$94K
LCM
71
Landscape Capital Management
New Jersey
$90K +$84K +807 New
PCM
72
Prelude Capital Management
New York
$69K -$160K -1,541 -73%
Legal & General Group
73
Legal & General Group
United Kingdom
$67K -$5.83K -56 -9%
Deutsche Bank
74
Deutsche Bank
Germany
$64K -$63.6K -611 -53%
SG Americas Securities
75
SG Americas Securities
New York
$56K +$48.8K +469 New

SRGA Hedge Fund Activity: Q1 2017 in Review

95 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2017, worth a combined $161M — up 9% from $148M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SRGA and 8 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 43 added.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was First Light Asset Management, exiting entirely with an estimated $1.65M sold.

  • 95 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2017, down from 108 in Q4 2016.
  • Funds reported $161M of Surgalign Holdings, Inc. Common Stock stock for Q1 2017, up 9% quarter-over-quarter.
  • 8 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2017 and 14 closed out, a net change of -6 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $17.8M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2017 was First Light Asset Management, an estimated $1.65M sold.

Based on aggregated 13F filings for Q1 2017.